Centuple Global share news, announcements and annual reports
BSE: 531099Pharmaceuticals & BiotechnologySmall Cap
CENTUPLE GLOBAL LIMITED · Face value ₹10 Face value. The nominal value of one share as the company issued it, the unit its share capital is counted in and a dividend can be stated as a percentage of; it has no link to the share price. Face value in the glossary · Listed Sep 1995
Last close ₹33.00down ₹1.56 (4.51%)
Share price at the BSE close on 2 Nov 2026. Previous close ₹34.56.
2 Nov: open ₹35.99, high ₹35.99, low ₹32.90
52-week range of traded prices to 2 Nov 2026
₹28.42Low, 21 Sep 2026₹144.40High, 7 Jan 2026
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies. Market capitalisation: how it is worked out
- ₹18 Cr3,666th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. Price to earnings, trailing: how it is worked out
- 14.61
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. Price to book: how it is worked out
- 8.74
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- Nonein the last 12 months
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it.
- 94.1%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet.
- 22.8%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026.
- 3.26
- Volume, BSEVolume. Shares traded on the last trading day. Volume in the glossary
- 224
Centuple Global results
72 filed, newest first. Page 2 of 2.
Feb 2015
Nov 2014
Aug 2014
May 2014
Feb 2014
Nov 2013
Aug 2013
14 Aug · Results
Jun 2013
10 Jun · Results
Feb 2013
8 Feb · Results
Nov 2012
7 Nov · Results
Aug 2012
14 Aug · Results
May 2012
15 May · Results
Feb 2012
14 Feb · Results
Nov 2011
12 Nov · Results
Aug 2011
18 Aug · Results
May 2011
16 May · Results
Apr 2011
29 Apr · Results
With reference to the earlier announcement dated April 20, 2011 regarding Publish Audited Results, Rubra Medicaments Ltd has now informed BSE that due to some unavoidable circumstances, ....20 Apr · Results
Company shall submit Audited Financial Results for the entire Financial Year ended on March 31, 2011 with in 60 days from the end of the ....
Feb 2011
3 Feb · Results
Nov 2010
8 Nov · Results
Aug 2010
4 Aug · Results
Jun 2010
21 Jun · Results